Hiroyuki Uemura
Director/Board Member bei TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
Profil
Hiroyuki Uemura is currently an Outside Director at ELIIY Power Co., Ltd.
and an Independent Outside Director at Taisho Pharmaceutical Holdings Co., Ltd.
He was previously the President & Chief Executive Officer at Mitsui Sumitomo Insurance Co. Ltd., a Director at Hochiki Corp., and a Member-Supervisory Board at Taisho Pharmaceutical Co., Ltd.
He also served as an Independent Outside Director at Hochiki Corp.
Aktive Positionen von Hiroyuki Uemura
Unternehmen | Position | Beginn |
---|---|---|
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. | Director/Board Member | 01.06.2015 |
ELIIY Power Co., Ltd.
ELIIY Power Co., Ltd. Electrical ProductsProducer Manufacturing ELIIY Power Co., Ltd. develops and manufactures electricity storage systems. It offers general-purpose products such as electricity storage system for indoor use; stationary electricity storage systems; and general-purpose electricity storage system for industrial use. The firm also manufactures custom-built products including high-capacity electricity storage systems. The company was founded by Hiroichi Yoshida on September 28, 2006 and is headquartered in Tokyo, Japan. | Director/Board Member | - |
Ehemalige bekannte Positionen von Hiroyuki Uemura
Unternehmen | Position | Ende |
---|---|---|
HOCHIKI CORPORATION | Director/Board Member | 01.06.2004 |
Taisho Pharmaceutical Co., Ltd.
Taisho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan. | Director/Board Member | - |
HOCHIKI CORPORATION | Director/Board Member | - |
Mitsui Sumitomo Insurance Co. Ltd.
Mitsui Sumitomo Insurance Co. Ltd. Multi-Line InsuranceFinance Mitsui Sumitomo Insurance Co., Ltd. engages in the non-life insurance business of the MS&AD Insurance Group. It operates through the following segments: Domestic Property and Casualty Insurance, Overseas Operations, and Others. The Domestic Property and Casualty Insurance segment handles fire, marine, accident, automobile and automobile damage liability insurance services. The Overseas Operations segment provides the non-life insurance solutions to clients outside in the Japan. The Others segment consists of financial and risk-related services. It also provides the insurance and financial service businesses globally. The company was founded on October 21, 1918 and is headquartered in Tokyo, Japan. | President | 20.09.2010 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
HOCHIKI CORPORATION | Electronic Technology |
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
Private Unternehmen | 3 |
---|---|
Mitsui Sumitomo Insurance Co. Ltd.
Mitsui Sumitomo Insurance Co. Ltd. Multi-Line InsuranceFinance Mitsui Sumitomo Insurance Co., Ltd. engages in the non-life insurance business of the MS&AD Insurance Group. It operates through the following segments: Domestic Property and Casualty Insurance, Overseas Operations, and Others. The Domestic Property and Casualty Insurance segment handles fire, marine, accident, automobile and automobile damage liability insurance services. The Overseas Operations segment provides the non-life insurance solutions to clients outside in the Japan. The Others segment consists of financial and risk-related services. It also provides the insurance and financial service businesses globally. The company was founded on October 21, 1918 and is headquartered in Tokyo, Japan. | Finance |
Taisho Pharmaceutical Co., Ltd.
Taisho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan. | Health Technology |
ELIIY Power Co., Ltd.
ELIIY Power Co., Ltd. Electrical ProductsProducer Manufacturing ELIIY Power Co., Ltd. develops and manufactures electricity storage systems. It offers general-purpose products such as electricity storage system for indoor use; stationary electricity storage systems; and general-purpose electricity storage system for industrial use. The firm also manufactures custom-built products including high-capacity electricity storage systems. The company was founded by Hiroichi Yoshida on September 28, 2006 and is headquartered in Tokyo, Japan. | Producer Manufacturing |